Next Article in Journal
Improvement of Corrosion Resistance for Gray Cast Iron in Palm Biodiesel Application Using Thermoreactive Diffusion Niobium Carbide (NbC) Coating
Next Article in Special Issue
Thin Film Thermoelectric Materials: Classification, Characterization, and Potential for Wearable Applications
Previous Article in Journal
Characterization of Flake Boron Nitride Prepared from the Low Temperature Combustion Synthesized Precursor and Its Application for Dye Adsorption
Previous Article in Special Issue
Porous Zinc Oxide Thin Films: Synthesis Approaches and Applications
Open AccessArticle

Surface Modification of Esophageal Stent Materials by a Drug-Eluting Layer for Better Anti-Restenosis Function

1
School of Life Science, Zhengzhou University, Zhengzhou 450000, China
2
School of Materials Science and Engineering, Zhengzhou University, Zhengzhou 450000, China
*
Authors to whom correspondence should be addressed.
Coatings 2018, 8(6), 215; https://doi.org/10.3390/coatings8060215
Received: 5 April 2018 / Revised: 19 May 2018 / Accepted: 31 May 2018 / Published: 6 June 2018
  |  
PDF [5177 KB, uploaded 6 June 2018]
  |  

Abstract

It is generally accepted that stent implantation is the mainstream therapy in clinics for esophageal cancer in the later period. However, the restenosis caused by tumor cells, epithelial cells, and fibroblasts seriously interferes with the stent medical application and limits its long-term services. To address this conundrum, a series of drug-eluting stents were invented and verified to be feasible in the early stage after implantation, but the limited drug loading and good cell compatibility of the stent materials may lead to more serious restenosis and further endanger the patient’s life. In previous work, we modified the esophageal stent material 317L stainless steel (317L SS) surface with a poly-dopamine/poly-ethylenimine layer (PDA/PEI), which had strong anti-tumor functions. In this contribution, we employed a usual drug in clinic, 5-fluorouracil (5-Fu), with series of density onto the PDA/PEI modified 317L SS to investigate the influence of 5-Fu immobilization on the anti-restenosis function. The surface characterization including 5-Fu quantity, atomic force microscopy (AFM). Water contact angle measurement indicated successful preparation of the PDA/PEI/5-Fu layers. The spectrophotometric characterization revealed that the immobilized 5-Fu rapidly released over 24 h. However, the Eca109, Het-1A, and L929 cells culture results suggested that the released 5-Fu made a significant contribution to improving the apoptosis and necrosis of these pathological cells, and the PDA/PEI/5-Fu layers maintain the consistent anti-restenosis function on their surfaces with the PDA/PEI layer after 24 h. All the results demonstrated the PDA/PEI/5-Fu layers’ excellent ability to suppress esophageal tumor cells, epithelial cells, and fibroblasts, suggesting a potential application on the surface modification of esophageal stents for better anti-restenosis function. View Full-Text
Keywords: esophageal stent materials; anti-restenosis; functional layer; poly-dopamine; 5-fluorouracil; poly-ethylenimine esophageal stent materials; anti-restenosis; functional layer; poly-dopamine; 5-fluorouracil; poly-ethylenimine
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Bai, Y.; Zhang, K.; Xu, R.; Liu, H.; Guan, F.; Luo, H.; Chen, Y.; Li, J. Surface Modification of Esophageal Stent Materials by a Drug-Eluting Layer for Better Anti-Restenosis Function. Coatings 2018, 8, 215.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Coatings EISSN 2079-6412 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top